Eliquis Regulatory Post Marketing Surveillance (rPMS)

Eliquis (Apixaban) Regulatory Post Marketing Surveillance in Clinical Practice for Venous Thromboembolism (VTE) Prevention

The objective of this regulatory Post-Marketing Surveillance in Korea is to reconfirm the clinical usefulness of Eliquis through collecting, reviewing, identifying and verifying the safety and effectiveness information about Eliquis in general practice

Inclusion Criteria:

• Signed data release
• Patients undergoing elective total hip replacement arthroplasty or elective total knee replacement arthroplasty

Exclusion Criteria:

• Being treated for an indication not approved for the use of Eliquis® in Korea
• Is contraindicated for the use of Eliquis® as described in the Korean label